Sleep Number Corporation SNBRQ
0.02
0.00
0.00%
as of 25 Sep
- Market cap
- $2.9M
- P/E
- 0.0×
Follow SNBRQ
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.10 | 0.11 | 0.14 | 0.03 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
40.51 | (25.37) | 103.19 | (5.34) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.10 | 0.11 | 0.14 | 0.03 | |
EV/EBITDA |
2.07 | 7.00 | 21.28 | 0.00 | |
EV/Operating CF |
31.83 | (5.55) | (58.45) | (4.75) | |
EV/FCF |
(9.13) | (3.12) | (8.72) | (1.43) | |
Quick Ratio |
0.02 | 0.03 | 0.02 | 0.02 | |
Current Ratio |
0.19 | 0.19 | 0.16 | 0.15 | |
Net Debt/EBITDA |
(0.10) | 0.05 | (0.34) | 0.06 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.81 | 1.79 | 1.83 | 1.81 | |
Operating CF/Net income |
(0.15) | 0.16 | (0.03) | 0.15 | |
Capex/Depreciation |
(0.47) | (0.28) | (0.19) | (0.44) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.87% | 2.14% | 1.81% | 1.68% | |
Selling, General and Administrative Expense of Revenue |
53.69% | 58.10% | 55.24% | 60.94% | |
Intangible Assets out of Total Assets |
0.08 | 0.09 | 0.10 | 0.10 | |
Share Based Compensation of Revenue |
0.47% | (0.23%) | 0.45% | 0.89% | |
Graham Net Nets |
(7.17) | (6.83) | (5.73) | (27.16) | |
Graham Number |
29.32 | 41.74 | 57.19 | 68.07 | |
Earnings Yield |
(26.92%) | (48.58%) | (67.97%) | (420.00%) | |
Free Cash Flow Yield |
(10.86%) | (31.84%) | (11.36%) | (67.57%) | |
Revenue per Share |
14.32 | 14.93 | 15.18 | 13.87 | |
Operating CF per Share |
0.17 | (0.28) | 0.08 | (0.34) | |
Capex per Share |
(0.29) | (0.17) | (0.11) | (0.24) | |
Free Cash Flow per Share |
(0.13) | (0.44) | (0.03) | (0.57) | |
Cash per Share |
0.06 | 0.06 | 0.07 | 0.06 | |
Shareholders Equity per Share |
(20.99) | (22.70) | (25.28) | (27.24) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(20.99) | (22.70) | (25.28) | (27.24) | |
Free Cash Flow |
(2.91) | (10.19) | (0.64) | (13.19) | |
Working Capital |
(727.70) | (729.01) | (762.59) | (788.23) | |
Capital Expenditures |
(6.73) | (3.84) | (2.52) | (5.44) | |
Net Current Asset Value |
(1,109.67) | (1,100.93) | (1,108.58) | (1,123.85) | |
EV/EBIT |
11.82 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
(7.63%) | (11.60%) | (16.84%) | (15.77%) | |
Price to Operating Income |
11.92 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
18.14 | 21.42 | 16.51 | 13.79 | |
Average Payables |
108.63 | 117.48 | 112.80 | 115.35 | |
Average Inventory |
97.65 | 91.44 | 92.69 | 91.05 | |
Average Assets |
844.08 | 807.02 | 770.44 | 738.90 | |
Average Common Equity |
(463.83) | (485.06) | (515.03) | (541.58) |
Columns are period end dates